Contact this trialFirst, we need to learn more about you.
Alkylating agents
VS-6063 + Chemotherapy for Ovarian Cancer
Recruiting2 awardsPhase 1 & 2
San Diego, California
This trial is testing a new treatment for ovarian cancer that combines an experimental drug, VS-6063, with two approved chemotherapy drugs, carboplatin and paclitaxel. The goal is to see if this combination is safe and can reduce cancer cells. Patients will take VS-6063 by mouth and receive the other two drugs through infusions.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service